Hans‐Jakob Steiger

Papers

Total Citations

H-Index

About

Hans‐Jakob Steiger is a pioneering neuro-oncology researcher whose work bridges the intersection of stem cell biology, neurotransmitter signaling, and high-throughput drug discovery. His most cited study, "Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma" (2020, 16 citations), exemplifies his innovative approach: using robotic automation to screen existing drugs for repurposing against glioblastoma stem cells. This work directly addresses the critical clinical need for therapies targeting the heterogeneous, stem-cell-driven hierarchy of this lethal brain tumor, revealing that neurotransmitter microenvironments can be exploited therapeutically. Steiger’s major contribution lies in demonstrating how automated platforms can uncover unexpected connections—such as repurposing a Parkinson’s drug to disrupt cancer stem cell maintenance—offering a faster path to clinical translation. His research has profound implications for personalized oncology, showing that the brain’s chemical landscape is not just a bystander but a druggable vulnerability in glioblastoma. By merging robotics with stem cell biology, Steiger is redefining how we identify treatments for one of medicine’s most intractable cancers, making his work essential reading for anyone interested in the future of precision neuro-oncology.